AIM IMMUNOTECH INC. Research and Development Expense
AIM IMMUNOTECH INC. (AIM) reported Research and Development Expense of $589.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- AIM IMMUNOTECH INC. research and development expense for the quarter ending 2026-06-30 was $589.00K, a 49.83% decline year-over-year.
- AIM IMMUNOTECH INC. research and development expense for the quarter ending 2026-03-31 was $482.00K, a 55.37% decline year-over-year.
- AIM IMMUNOTECH INC. research and development expense for the quarter ending 2025-12-31 was $1.06M, a 36.12% decline year-over-year.
- AIM IMMUNOTECH INC. research and development expense for the quarter ending 2025-09-30 was $607.00K, a 57.76% decline year-over-year.
- AIM IMMUNOTECH INC. research and development expense for fiscal 2025 was $3.92M, a 36.68% decline from fiscal 2024.
- AIM IMMUNOTECH INC. research and development expense for fiscal 2024 was $6.20M, a 43.35% decline from fiscal 2023.
- AIM IMMUNOTECH INC. research and development expense for fiscal 2023 was $10.94M, a 56.49% increase from fiscal 2022.
- AIM IMMUNOTECH INC. research and development expense for fiscal 2022 was $6.99M, a 8.89% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $589.00K 10-Q · filed 2026-08-07 | $1.07M 10-Q · filed 2026-08-07 | $2.13M derived: sum of 3 quarters · filed 2026-08-07 | $2.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $482.00K 10-Q · filed 2026-05-15 | $1.54M derived: sum of 2 quarters · filed 2026-05-15 | $2.15M derived: sum of 3 quarters · filed 2026-05-15 | $3.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.67M derived: sum of 2 quarters · filed 2026-03-27 | $2.84M derived: sum of 3 quarters · filed 2026-08-07 | $3.92M 10-K · filed 2026-03-27 |
| 2025-09-30 | $607.00K 10-Q · filed 2025-11-17 | $1.78M derived: sum of 2 quarters · filed 2026-08-07 | $2.86M 10-Q · filed 2025-11-17 | $4.53M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.17M 10-Q · filed 2026-08-07 | $2.25M 10-Q · filed 2026-08-07 | $3.92M derived: sum of 3 quarters · filed 2026-08-07 | $5.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.08M 10-Q · filed 2026-05-15 | $2.74M derived: sum of 2 quarters · filed 2026-05-15 | $4.18M derived: sum of 3 quarters · filed 2026-05-15 | $5.33M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.10M derived: sum of 2 quarters · filed 2026-03-27 | $4.25M derived: sum of 3 quarters · filed 2026-03-27 | $6.20M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.44M 10-Q · filed 2025-11-17 | $2.58M derived: sum of 2 quarters · filed 2025-11-17 | $4.53M 10-Q · filed 2025-11-17 | $7.73M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-14 | $3.10M 10-Q · filed 2025-08-14 | $6.30M derived: sum of 3 quarters · filed 2025-08-14 | $9.03M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.95M 10-Q · filed 2025-05-15 | $5.15M derived: sum of 2 quarters · filed 2025-05-15 | $7.88M derived: sum of 3 quarters · filed 2025-05-15 | $10.84M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.93M derived: sum of 2 quarters · filed 2025-03-27 | $8.89M derived: sum of 3 quarters · filed 2025-03-27 | $10.94M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.73M 10-Q · filed 2024-11-14 | $5.69M derived: sum of 2 quarters · filed 2024-11-14 | $7.74M 10-Q · filed 2024-11-14 | $9.85M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $2.95M 10-Q · filed 2024-08-14 | $5.00M 10-Q · filed 2024-08-14 | $7.11M derived: sum of 3 quarters · filed 2024-08-14 | $8.48M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $2.05M 10-Q · filed 2024-05-15 | $4.16M derived: sum of 2 quarters · filed 2024-05-15 | $5.53M derived: sum of 3 quarters · filed 2024-05-15 | $8.01M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.48M derived: sum of 2 quarters · filed 2024-04-01 | $5.95M derived: sum of 3 quarters · filed 2024-04-01 | $6.99M 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.37M 10-Q · filed 2023-11-14 | $3.85M derived: sum of 2 quarters · filed 2023-11-14 | $4.88M 10-Q · filed 2023-11-14 | $7.81M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $2.48M 10-Q · filed 2023-08-14 | $3.51M 10-Q · filed 2023-08-14 | $6.43M derived: sum of 3 quarters · filed 2023-08-14 | $8.44M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-15 | $3.96M derived: sum of 2 quarters · filed 2023-05-15 | $5.96M derived: sum of 3 quarters · filed 2023-05-15 | $7.28M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.93M derived: sum of 2 quarters · filed 2023-03-31 | $6.25M derived: sum of 3 quarters · filed 2023-03-31 | $7.67M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.01M 10-Q · filed 2022-11-14 | $3.32M derived: sum of 2 quarters · filed 2022-11-14 | $4.75M 10-Q · filed 2022-11-14 | $7.02M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.32M 10-Q · filed 2022-08-15 | $2.74M 10-Q · filed 2022-08-15 | $5.02M derived: sum of 3 quarters · filed 2022-08-15 | $6.12M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.42M 10-Q · filed 2022-05-13 | $3.70M derived: sum of 2 quarters · filed 2022-05-13 | $4.80M derived: sum of 3 quarters · filed 2022-05-13 | $6.26M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.38M derived: sum of 2 quarters · filed 2022-03-31 | $4.84M derived: sum of 3 quarters · filed 2022-03-31 | $5.72M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-15 | $2.56M derived: sum of 2 quarters · filed 2021-11-15 | $3.44M 10-Q · filed 2021-11-15 | $4.90M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.46M 10-Q · filed 2021-08-16 | $2.34M 10-Q · filed 2021-08-16 | $3.80M derived: sum of 3 quarters · filed 2021-08-16 | $4.99M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $898.00K 10-Q · filed 2021-05-17 | $2.33M derived: sum of 2 quarters · filed 2021-05-17 | $3.52M derived: sum of 3 quarters · filed 2021-05-17 | $4.62M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.63M derived: sum of 2 quarters · filed 2021-03-31 | $3.72M derived: sum of 3 quarters · filed 2021-03-31 | $4.65M 10-K · filed 2021-03-31 |
| 2019-09-30 | $1.19M 10-Q · filed 2020-11-12 | $2.29M derived: sum of 2 quarters · filed 2020-11-12 | $3.21M 10-Q · filed 2020-11-12 | $4.20M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.10M 10-Q · filed 2020-08-14 | $2.02M 10-Q · filed 2020-08-14 | $3.01M derived: sum of 3 quarters · filed 2020-08-14 | $4.61M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $928.00K 10-Q · filed 2020-05-14 | $1.92M derived: sum of 2 quarters · filed 2020-05-14 | $3.51M derived: sum of 3 quarters · filed 2020-05-14 | $4.85M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $987.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.58M derived: sum of 2 quarters · filed 2020-03-30 | $3.92M derived: sum of 3 quarters · filed 2020-03-30 | $4.78M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.59M 10-Q · filed 2019-11-14 | $2.94M derived: sum of 2 quarters · filed 2019-11-14 | $3.79M 10-Q · filed 2019-11-14 | $4.61M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.34M 10-Q · filed 2019-08-14 | $2.20M 10-Q · filed 2019-08-14 | $3.01M derived: sum of 3 quarters · filed 2019-08-14 | $3.80M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $855.00K 10-Q · filed 2019-05-15 | $1.67M derived: sum of 2 quarters · filed 2019-05-15 | $2.46M derived: sum of 3 quarters · filed 2019-05-15 | $3.56M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.60M derived: sum of 2 quarters · filed 2019-04-01 | $2.71M derived: sum of 3 quarters · filed 2019-04-01 | $4.10M 10-K · filed 2019-04-01 |
| 2017-09-30 | $787.00K 10-Q · filed 2018-11-14 | $1.89M derived: sum of 2 quarters · filed 2018-11-14 | $3.28M 10-Q · filed 2018-11-14 | $5.15M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $1.11M 10-Q · filed 2018-08-14 | $2.50M 10-Q · filed 2018-08-14 | $4.36M derived: sum of 3 quarters · filed 2018-08-14 | $5.70M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.39M 10-Q · filed 2018-05-15 | $3.25M derived: sum of 2 quarters · filed 2018-05-15 | $4.60M derived: sum of 3 quarters · filed 2018-05-15 | $5.50M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $3.21M derived: sum of 2 quarters · filed 2018-03-30 | $4.11M derived: sum of 3 quarters · filed 2018-03-30 | $5.11M 10-K · filed 2018-03-30 |
| 2016-09-30 | $1.34M 10-Q · filed 2017-11-14 | $2.24M derived: sum of 2 quarters · filed 2017-11-14 | $3.24M 10-Q · filed 2017-11-14 | $4.20M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $900.00K 10-Q · filed 2017-08-14 | $1.90M 10-Q · filed 2017-08-14 | $2.86M derived: sum of 3 quarters · filed 2018-03-30 | $4.83M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | $1.00M 10-Q · filed 2017-05-15 | $1.96M derived: sum of 2 quarters · filed 2018-03-30 | $3.93M derived: sum of 3 quarters · filed 2018-03-30 | $6.37M derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $957.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $2.92M derived: sum of 2 quarters · filed 2018-03-30 | $5.36M derived: sum of 3 quarters · filed 2018-03-30 | $8.04M 10-K · filed 2018-03-30 |
| 2015-09-30 | $1.97M 10-Q · filed 2016-11-14 | $4.41M derived: sum of 2 quarters · filed 2016-11-14 | $7.08M 10-Q · filed 2016-11-14 | $9.52M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $2.44M 10-Q · filed 2016-08-15 | $5.11M 10-Q · filed 2016-08-15 | $7.55M derived: sum of 3 quarters · filed 2017-03-31 | $9.45M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $2.67M 10-Q · filed 2016-05-16 | $5.11M derived: sum of 2 quarters · filed 2017-03-31 | $7.01M derived: sum of 3 quarters · filed 2017-03-31 | $9.34M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $4.33M derived: sum of 2 quarters · filed 2017-03-31 | $6.66M derived: sum of 3 quarters · filed 2017-03-31 | $8.99M 10-K · filed 2017-03-31 |
| 2014-09-30 | $1.89M 10-Q · filed 2015-11-16 | $4.22M derived: sum of 2 quarters · filed 2015-11-16 | $6.55M 10-Q · filed 2015-11-16 | $8.08M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $2.33M 10-Q · filed 2015-08-12 | $4.66M 10-Q · filed 2015-08-12 | $6.19M derived: sum of 3 quarters · filed 2016-03-29 | $8.36M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $2.33M 10-Q · filed 2015-05-12 | $3.86M derived: sum of 2 quarters · filed 2016-03-29 | $6.03M derived: sum of 3 quarters · filed 2016-03-29 | $8.35M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $3.71M derived: sum of 2 quarters · filed 2016-03-29 | $6.02M derived: sum of 3 quarters · filed 2016-03-29 | $8.36M 10-K · filed 2016-03-29 |
| 2013-09-30 | $2.17M 10-Q · filed 2014-11-07 | $4.49M derived: sum of 2 quarters · filed 2014-11-07 | $6.83M 10-Q · filed 2014-11-07 | $10.58M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-06-30 | $2.32M 10-Q · filed 2014-08-08 | $4.65M 10-Q · filed 2014-08-08 | $8.40M derived: sum of 3 quarters · filed 2015-03-19 | $10.76M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-03-31 | $2.34M 10-Q · filed 2014-05-09 | $6.09M derived: sum of 2 quarters · filed 2015-03-19 | $8.44M derived: sum of 3 quarters · filed 2015-03-19 | $10.18M derived: sum of 4 quarters · filed 2015-03-19 |
| 2012-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $6.11M derived: sum of 2 quarters · filed 2015-03-19 | $7.84M derived: sum of 3 quarters · filed 2015-03-19 | $9.51M 10-K · filed 2015-03-19 |
| 2012-09-30 | $2.36M 10-Q · filed 2013-11-08 | $4.09M derived: sum of 2 quarters · filed 2013-11-08 | $5.76M 10-Q · filed 2013-11-08 | $7.47M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $1.74M 10-Q · filed 2013-08-09 | $3.40M 10-Q · filed 2013-08-09 | $5.11M derived: sum of 3 quarters · filed 2014-03-14 | $6.86M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $1.67M 10-Q · filed 2013-05-08 | $3.37M derived: sum of 2 quarters · filed 2014-03-14 | $5.12M derived: sum of 3 quarters · filed 2014-03-14 | $6.75M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $3.46M derived: sum of 2 quarters · filed 2014-03-14 | $5.08M derived: sum of 3 quarters · filed 2014-03-14 | $6.72M 10-K · filed 2014-03-14 |
| 2011-09-30 | $1.75M 10-Q · filed 2012-11-02 | $3.37M derived: sum of 2 quarters · filed 2012-11-02 | $5.01M 10-Q · filed 2012-11-02 | $7.13M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $1.62M 10-Q · filed 2012-08-08 | $3.26M 10-Q · filed 2012-08-08 | $5.38M derived: sum of 3 quarters · filed 2013-03-18 | $7.19M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $1.64M 10-Q · filed 2012-05-07 | $3.75M derived: sum of 2 quarters · filed 2013-03-18 | $5.56M derived: sum of 3 quarters · filed 2013-03-18 | $7.26M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $3.92M derived: sum of 2 quarters · filed 2013-03-18 | $5.62M derived: sum of 3 quarters · filed 2013-03-18 | $7.61M 10-K · filed 2013-03-18 |
| 2010-09-30 | $1.81M 10-Q · filed 2011-11-09 | $3.50M derived: sum of 2 quarters · filed 2011-11-09 | $5.50M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.69M 10-Q · filed 2011-08-05 | $3.69M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $7.00M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |